Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric Assay
Authors:
- William E. ZackertWZWilliam E. Zackert
- James P. YangJYJames P. Yang
- Eric H. KurhtsEKEric H. Kurhts
- Denis CallewaertDCDenis Callewaert
- Ryszard DworskiRDRyszard Dworski
- Kazuo KanaiKKKazuo Kanai
- Douglass TaberDTDouglass Taber
- Kevin MooreKMKevin Moore
- John A. OatesJOJohn A. Oates
- L.Jackson RobertsLRL.Jackson Roberts
- 1 May 1999
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 269 (2) , 326-331
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The isoprostanes: Unique bioactive products of lipid peroxidationProgress in Lipid Research, 1997
- Evidence that the F2-isoprostane, 8-epi-prostaglandin F2α, is formed in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Oxidative stress status: An introductionFree Radical Biology and Medicine, 1991
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- [1] Role of free radicals and catalytic metal ions in human disease: An overview1990
- Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoidsAnalytical Biochemistry, 1990
- Free Radicals in Medicine. II. Involvement in Human DiseaseMayo Clinic Proceedings, 1988
- Measurement of renal and non-renal eicosanoid synthesisThe American Journal of Medicine, 1986
- Dietary Carcinogens and AnticarcinogensScience, 1983
- The aging process.Proceedings of the National Academy of Sciences, 1981